Bacterin to Present at the Noble 8th Annual Equity Conference on January 17, 2012
PR NewswirePress Release: Bacterin International Holdings, Inc. –
BELGRADE, Mont. , Jan. 11, 2012 /PRNewswire/ --Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, has been invited to present at the Noble Financial Capital Markets' 8th Annual Equity Conference. The conference will be held at the Hard Rock Hotel & Casino in Hollywood, Florida on January 17-18, 2012 .
Bacterin's chairman and CEO, Guy Cook , is scheduled to present on Tuesday, January 17, 2012 at 1:00 p.m. Eastern time , with one-on-one meetings held throughout the day. Management will discuss Bacterin's business plan and objectives for 2012.
The presentation will be video webcast live and available for replay here, or via the investor relations section of Bacterin's website at www.bacterin.com.
Bacterin reported record revenue of $7.5 million in the third quarter 2011, up 80% year-over-year. For 2012, management expects revenue of $53 million to $56 million .
The conference will showcase approximately 140 small and micro cap companies. Presenting companies encompass four general sectors: Healthcare, Technology, Software, Defense and Media/Entertainment.
For more information about the conference, please contact your Noble Financial sales representative.
PR NewswirePress Release: Bacterin International Holdings, Inc. –
BELGRADE, Mont. , Jan. 11, 2012 /PRNewswire/ --Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, has been invited to present at the Noble Financial Capital Markets' 8th Annual Equity Conference. The conference will be held at the Hard Rock Hotel & Casino in Hollywood, Florida on January 17-18, 2012 .
Bacterin's chairman and CEO, Guy Cook , is scheduled to present on Tuesday, January 17, 2012 at 1:00 p.m. Eastern time , with one-on-one meetings held throughout the day. Management will discuss Bacterin's business plan and objectives for 2012.
The presentation will be video webcast live and available for replay here, or via the investor relations section of Bacterin's website at www.bacterin.com.
Bacterin reported record revenue of $7.5 million in the third quarter 2011, up 80% year-over-year. For 2012, management expects revenue of $53 million to $56 million .
The conference will showcase approximately 140 small and micro cap companies. Presenting companies encompass four general sectors: Healthcare, Technology, Software, Defense and Media/Entertainment.
For more information about the conference, please contact your Noble Financial sales representative.
Recent XTNT News
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 05/13/2026 11:33:08 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 11:15:38 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 11:05:34 AM
- Xtant Medical Reports First Quarter 2026 Financial Results • PR Newswire (US) • 05/13/2026 11:00:00 AM
- Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026 • PR Newswire (US) • 05/07/2026 12:00:00 PM
- Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped • PR Newswire (US) • 05/06/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/13/2026 01:20:24 PM
- Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product • PR Newswire (US) • 04/13/2026 01:04:00 PM
- Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial • PR Newswire (US) • 04/09/2026 12:00:00 PM
- Xtant Medical shares drop nearly 5% as weak 2026 outlook overshadows Q4 beat • IH Market News • 03/31/2026 02:54:42 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 11:16:07 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 11:05:23 AM
- Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results • PR Newswire (US) • 03/31/2026 11:00:00 AM
- Xtant Medical to Announce Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026 • PR Newswire (US) • 03/25/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/02/2026 01:15:49 PM
- Xtant Medical Finalizes Companion Spine Transactions • PR Newswire (US) • 03/02/2026 01:00:00 PM
- Xtant Medical to Participate in the Canaccord Genuity 2026 Musculoskeletal Conference • PR Newswire (US) • 02/25/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2026 10:00:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2026 09:15:32 PM
- Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata™ Synthetic Bone Graft • PR Newswire (US) • 12/11/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/03/2025 09:05:52 PM
- Xtant Medical Completes Sale of its Coflex® Assets and Paradigm OUS Businesses to Companion Spine • PR Newswire (US) • 12/01/2025 09:05:00 PM

